Dose escalation of TAS-117 in patients with advanced solid tumors

被引：0
|
作者：
Rodon, J. [1 ]
Arkenau, H-T. [2 ]
Funchain, P. [3 ]
Hervieu, A. [4 ]
Gao, L. [5 ]
Liu, M. [6 ]
Halim, A. [7 ]
Mina, M. [8 ]
Takahashi, O. [8 ]
Benhadji, K. [8 ]
Delaloge, S. [9 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Invest Canc Therapeut, Houston, TX USA
[2] Sarah Cannon Res Inst, Onocl, London, England
[3] Cleveland Clin, Dept Hematol & Med Oncol, Cleveland, OH USA
[4] Ctr Georges Francois Leclerc, Med Oncol, Dijon, France
[5] Taiho Oncol Inc, Dept Clin Pharmacol & Pharmacometr, Princeton, NJ USA
[6] Taiho Oncol Inc, Biostat, Princeton, NJ USA
[7] Taiho Oncol Inc, Biomarkers & Compan Diagnost, Princeton, NJ USA
[8] Taiho Oncol Inc, Clin Dev, Princeton, NJ USA
[9] Inst Gustave Roussy, Intercept Med Sci Programme, Villejuif, France
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.596
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
467P
引用
收藏
页码：S754 / S755
页数：2
相关论文
共 50 条
  • [21] Phase I dose escalation study of docetaxel with filgrastim support in patients with advanced solid tumors
    Gregory A. Masters
    Bruce E. Brockstein
    Sridhar Mani
    Mark J. Ratain
    Medical Oncology, 2003, 20 : 7 - 12
  • [22] A phase I dose escalation study of sunitinib plus capecitabine in patients with advanced solid tumors
    Sweeney, C.
    Verschraegen, C.
    Chiorean, G.
    Lee, F.
    Jones, S.
    Tye, L.
    Bello, A.
    Chao, R.
    Burris, H., III
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [23] A dose escalation study of docetaxel plus capecitabine in combination with gemcitabine in patients with advanced solid tumors
    Amarantidis, K.
    Houhouli, K.
    Papatheodorou, K.
    Miloussis, A.
    Matthaios, D.
    Chatzaki, E.
    Lyrantzopoulos, N.
    Tsaroucha, A.
    Tentes, A.
    Kakolyris, S.
    ONCOLOGY RESEARCH, 2006, 16 (06) : 281 - 287
  • [24] A dose escalation, safety, and tolerability study of MN-029 in patients with advanced solid tumors
    Anne M. Traynor
    Michael S. Gordon
    Dona Alberti
    David S. Mendelson
    Mark S. Munsey
    George Wilding
    Richard E. Gammans
    William L. Read
    Investigational New Drugs, 2010, 28 : 509 - 515
  • [25] Dose escalation and expansion cohort study for DS-8895a in patients with advanced solid tumors
    Satoh, Taroh
    Shitara, Kohei
    Iwasa, Satoru
    Yamaguchi, Kensei
    Muro, Kei
    Komatsu, Yoshito
    Nishina, Tomohiro
    Esaki, Taito
    Hasegawa, Jun
    Kakurai, Yasuyuki
    Kamiyama, Emi
    Nakata, Tomoko
    Nakamura, Kota
    Hyodo, Ichinosuke
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [26] A dose escalation, safety, and tolerability study of MN-029 in patients with advanced solid tumors
    Traynor, Anne M.
    Gordon, Michael S.
    Alberti, Dona
    Mendelson, David S.
    Munsey, Mark S.
    Wilding, George
    Gammans, Richard E.
    Read, William L.
    INVESTIGATIONAL NEW DRUGS, 2010, 28 (04) : 509 - 515
  • [27] A dose-escalation study of pegylated liposomal doxorubicin and oxaliplatin in patients with advanced solid tumors
    Kotsakis, A.
    Kouroussis, Ch.
    Androulakis, N.
    Agelaki, S.
    Kalbakis, K.
    Vamvakas, L.
    Vardakis, N.
    Kalykaki, A.
    Polyzos, A.
    Georgoulias, V.
    Mavroudis, D.
    ONCOLOGY, 2006, 71 (3-4) : 190 - 196
  • [28] A dose escalation study of docetaxel plus capecitabine in combination with oxaliplatin in patients with advanced solid tumors
    Amarantidis, Kyriakos
    Xenidis, Nikolaos
    Chelis, Leonidas
    Chiotis, Anestis
    Tentes, Apostolos
    Chatzaki, Ekaterini
    Kortsaris, Alexandros
    Polychronidis, A.
    Karakitsos, Petros
    Kakolyris, Stylianos
    ACTA ONCOLOGICA, 2010, 49 (02) : 245 - 251
  • [29] A dose escalation and pharmacokinetic study of the biweekly administration of paclitaxel, gemcitabine and oxaliplatin in patients with advanced solid tumors
    Saridaki, Zacharenia
    Pappas, Periklis
    Souglakos, John
    Nikolaidou, Martha
    Vardakis, Nikolaos
    Kotsakis, Athanasios
    Marselos, Marios
    Georgoulias, Vassilis
    Mavroudis, Dimitris
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 65 (01) : 121 - 128
  • [30] Phase I/Ib dose-escalation study of aveluma in Chinese patients with advanced solid tumors
    Wu, Yi-Long
    Cheng, Ying
    Chen, Huajun
    Tu, Haiyan
    Xu, Chongrui
    Wang, Zhen
    Liu, Ying
    Xin, Ying
    Lou, Haizhou
    Wang, Wei
    Chin, Kevin
    Li, Dandan
    Zhao, Di
    Gao, Yanfei
    Xu, Wenping
    Pan, Hongming
    FUTURE ONCOLOGY, 2022,
12345